Accuray
Mika Nishimura is an accomplished operational partner at Gilde Healthcare since 2011, specializing in due diligence and deal flow in the life-science sector. Currently serving as an independent director for several companies, including Hoya, Accuray, and SI-BONE, Mika chairs multiple committees, focusing on healthcare compliance, corporate governance, and nominations. Previous roles include vice president at nVision Medical and Auxogyn, both of which achieved significant acquisitions. Mika founded The BLG Group, a consulting firm for medical device companies, and held senior positions at ev3, inc. An MBA graduate from Harvard Business School and summa cum laude graduate from Yale University, Mika has extensive expertise in commercialization and market strategy within the healthcare industry.
This person is not in any teams
This person is not in any offices
Accuray
7 followers
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives.